---
title: Candel Therapeutics | Pipeline
description: Explore our pipeline of viral immunotherapies designed for the treatment of solid tumors.
---

[Skip to content](https://candeltx.com/pipeline#main-content)

[![Candel Therapeutics Logo](https://candeltx.com/hubfs/logo-main-nav-1.svg "Candel Therapeutics Logo")](https://candeltx.com/?hsLang=en)

- CAN-2409 Mechanism of Action
- CAN-3110 Mechanism of Action
- [ Careers ](https://candeltx.com/careers)
- Investigator Portal

- [ About ](https://candeltx.com/about)
  
  Show submenu for About 
  
    - [ Leadership ](https://candeltx.com/leadership)
- [ Science ](https://candeltx.com/science)
- [ Pipeline ](https://candeltx.com/pipeline)
- [ Patients ](https://candeltx.com/patients)
- [ Providers ](https://candeltx.com/providers)
  
  Show submenu for Providers 
  
    - [ Clinical Trials ](https://candeltx.com/providers/#clinical-trials)
    - [ Investigator Login ](https://candeltx.com/investigator-login)
- [ Media ](https://candeltx.com/media)
- [ Investors ](https://ir.candeltx.com/)
- [ Careers ](https://candeltx.com/careers)
- [ Mail ](https://candeltx.com/contact)

- [ About ](https://candeltx.com/about)
  
  Show submenu for About 
  
    - [ Leadership ](https://candeltx.com/leadership)
- [ Science ](https://candeltx.com/science)
- [ Pipeline ](https://candeltx.com/pipeline)
- [ Patients ](https://candeltx.com/patients)
- [ Providers ](https://candeltx.com/providers)
  
  Show submenu for Providers 
  
    - [ Clinical Trials ](https://candeltx.com/providers/#clinical-trials)
    - [ Investigator Login ](https://candeltx.com/investigator-login)
- [ Media ](https://candeltx.com/media)
- [ Investors ](https://ir.candeltx.com/)
- [ Careers ](https://candeltx.com/careers)
- [ Mail ](https://candeltx.com/contact)

# Our Cancer Immunotherapy Development Pipeline

Our precision cancer therapies generate systemic therapeutic effects and have demonstrated favorable tolerability profiles to date. See the progress of our CAN-2409 and CAN-3110 platforms in development.

- [ Contact Us ](https://candeltx.com/contact?hsLang=en)

![Microscopic view capturing a t cell actively attacking an infected cell, featuring a transparent background, ideal for use in medical and scientific projects focused on immunology and biology](https://candeltx.com/hs-fs/hubfs/bg-hero-floating-cells.png?width=1147&height=878&name=bg-hero-floating-cells.png)

# Our Cancer Immunotherapy Development Pipeline

Our precision cancer therapies generate systemic therapeutic effects and have demonstrated favorable tolerability profiles to date. See the scientific progress of our aglatimagene besadenovec and linoserpaturev platforms in development.

- [ Contact Us ](https://candeltx.com/contact?hsLang=en)

![bg-hero-floating-cells](https://candeltx.com/hs-fs/hubfs/bg-hero-floating-cells.png?width=1147&height=878&name=bg-hero-floating-cells.png)

## Pipeline

We are currently evaluating our viral immunotherapies in a variety of solid tumors, including prostate, lung and brain cancer. For more information on our clinical studies, please visit our [science page](https://candeltx.com/science?hsLang=en) to learn more about our viral immunotherapy approach.

Program

Indication

 Preclinical

 Phase I

 Phase II

 Phase III

 BLA Readiness

### Adenovirus Platform

#### Aglatimagene Pancreatic Cancer*

 Borderline Resectable Pancreatic Adenocarcinoma, Fast Track Designation (FDA), Orphan Drug Designation (FDA)

 Phase II

#### Aglatimagene Lung Cancer

 NSCLC + PD-1/PD-(L)1,  
 Fast Track Designation (FDA)

 Phase III

#### Aglatimagene Prostate Cancer

 Localized, Intermediate/High Risk,   
 Fast Track Designation (FDA),   
Special Protocol Assessment (FDA), Regenerative Medicine Advanced Therapy Designation (FDA)

 BLA Readiness

### HSV Platform

#### Linoserpaturev Brain Cancer

 Recurrent High-Grade Glioma, Fast Track Designation (FDA), Orphan Drug Designation (FDA)

 Phase I

#### **enLIGHTEN™** Discovery Platform

 Solid Tumors

 Preclinical

*SPA – special protocol assessment *  
**Development paused, subject to additional funding*

## Clinical Trials

Discover active clinical trials and see the data from our completed prostate cancer clinical trial. 

- [ Learn about our Clinical Trials ](https://candeltx.com/providers/#clinical-trials)

![Teenage oncology patient talking with doctor. Oncologist treating teen girl with cancer and provide emotional support, helping her with anxiety and depression.](https://candeltx.com/hs-fs/hubfs/img-clinical-trials.webp?width=289&height=289&name=img-clinical-trials.webp "Teenage oncology patient talking with doctor. Oncologist treating teen girl with cancer and provide emotional support, helping her with anxiety and depression.")

## The Science

Learn why our viral immunotherapies offer the potential to improve overall survival and quality of life. 

- [ See the Science ](https://candeltx.com/science?hsLang=en)

![Modified drugs blocks DNA synthesis in dividing tumor cells, leading to tumor cell death. Adenovirus capsid proteins 
attract immune cells to the tumor microenvironment. Activated immune cells then attack distant metastases.](https://candeltx.com/hs-fs/hubfs/img-the-science.webp?width=382&height=307&name=img-the-science.webp "Modified drugs blocks DNA synthesis in dividing tumor cells, leading to tumor cell death. Adenovirus capsid proteins 
attract immune cells to the tumor microenvironment. Activated immune cells then attack distant metastases.")

## Join us in bringing life-saving cancer therapies to patients everywhere. Explore Candel Therapeutics' corporate profile

- [ Invest in Innovation ](https://ir.candeltx.com/)

The products described on this website are investigational products. They have not been reviewed or approved by the U.S. Food and Drug Administration (FDA), and safety and effectiveness has not been established. 

## Explore

[![Contact](https://no-cache.hubspot.com/cta/default/50530382/interactive-202464911429.png) ](https://candeltx.com/hs/cta/wi/redirect?encryptedPayload=AVxigLIkfdkfu%2FyXe7%2BmlsMPf7AF5TwhzoeEsMAAQD8RVB6SWb6Kh5FJfiPDY%2FEu2VpnC6lmUdaZJIS6AnAGLDx88lMMJxvem70ZefEbGmDYuqxoLcK8woLIEEVBJNtkzm1ujQh1L3ICdeveFPVxWNmMJoy3I1jUJgdD3scXWMsuBv6JPEOoVTOMq60%3D&webInteractiveContentId=202464911429&portalId=50530382&hsLang=en)

- [ About ](https://candeltx.com/careers?hsLang=en)
- [ Patients ](https://candeltx.com/patients?hsLang=en)
- [ Science ](https://candeltx.com/science?hsLang=en)

[![candel logo white](https://candeltx.com/hubfs/logo-footer.svg "candel logo white")](https://candeltx.com/?hsLang=en)

- [ About ](https://candeltx.com/about)
- [ Science ](https://candeltx.com/science)
- [ Pipeline ](https://candeltx.com/pipeline)
- [ Patients ](https://candeltx.com/patients)
- [ Providers ](https://candeltx.com/providers)
- [ Media ](https://candeltx.com/media)
- [ Investors ](https://ir.candeltx.com/)
- [ Contact ](https://candeltx.com/contact)

- [ About ](https://candeltx.com/about)
- [ Science ](https://candeltx.com/science)
- [ Pipeline ](https://candeltx.com/pipeline)
- [ Patients ](https://candeltx.com/patients)
- [ Providers ](https://candeltx.com/providers)
- [ Media ](https://candeltx.com/media)
- [ Investors ](https://ir.candeltx.com/)
- [ Contact ](https://candeltx.com/contact)

© 2026 by Candel Therapeutics